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ABSTRACT 
 
 
 
BACKGROUND 
 
Jaundice is a frequent manifestation of biliary tract disorders. Evaluation and 
management of the patient with jaundice is one of the challenging problems confronting 
the surgeon. Despite technical advances, until 1980’s the operative modes of management 
of obstructive jaundice were associated with very high morbidity and mortality. During the 
last decade significant advances have been made in our understanding with regard to the 
pathogenesis, diagnosis, staging and efficacy of surgical and non-surgical management of 
obstructive jaundice. 
 
 
Obstructive of varied etiology is one of the common causes of admission to 
hospitals across Tamil Nadu. This study evaluates the history, clinical presentation, 
etiology and the different modalities of treatment of obstructive jaundice. 
 
METHODS 
 
From September 2013 to September 2014, 30 obstructive jaundice patients 
admitted to Thanjavur Medical College Hospital were evaluated regarding the clinical 
history and presentation, relevant investigations and operative procedures were performed 
and the outcome noted on follow up. 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
• Peak age groups were 51 to 70 years with M : F :: 66.67: 33.33%.  
 
• Jaundice was the main presentation.  
 
• Most common cause was gallstones.  
 
• Raised bilirubin & alkaline phosphatase was more pronounced in malignancy.  
 
• USG was the cheapest non-invasive diagnostic tool.  
 
• CBD Stones were treated by Cholecystectomy with CBD exploration and drainage by 
T Tube or choledochoduodenostomy  
 
• For benign stricture Roux en Y Hepatico-Jejunostomy with was done.  
 
• For malignancy either curative Whipple’s procedure /palliative cholecystojejunostomy 
were done.  
 
INTERPRETATION AND CONCLUSION 
 
• Common presentation – Jaundice.  
 
• Common cause – Gallstones.  
 
• USG is a reliable diagnostic tool.  
 
• CBD exploration and drainage for CBD stones has good outcome.  
 
• In malignancy, palliative procedures relieve the obstructive jaundice significantly.  
 
 
 
KEYWORDS 
 
Common bile duct; Ultrasonography; ERCP; Choledocholithiasis; Benign stricture; 
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 INTRODUCTION 
 
 
Jaundice is a frequent manifestation of biliary tract 
disorders and the evaluation and management of obstructive 
jaundice is a common problem faced by the general surgeon. 
Obstructive jaundice is strictly defined as a condition 
occurring due to a block in the pathway between the site of 
conjugation of bile in liver cells and the entry of bile into the 
duodenum through the ampulla. The block may be intrahepatic or 
extrahepatic in the bile duct.1 
 
       Despite the technical advances, the operative modes of 
management of obstructive jaundice were associated with very 
high morbidity and mortality. Yet, during the last decade 
significant advances have been made in our understanding with 
regard to the pathogenesis, diagnosis, staging and the efficacy of 
management of obstructive jaundice.2 
 
       Obstructive jaundice of varied etiology is one of the causes of 
admission to hospitals across Tamil Nadu. To diagnose the cause, 
site of obstruction and management of a case of surgical jaundice 
is indeed a challenging task for the surgeon. Hence, a 
 comprehensive study of the etiology, clinical presentation and 
management of obstructive jaundice is of paramount importance 
in the appropriate management of these patients. 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              
  
            OBJECTIVES OF THE STUDY 
 
 
• To study the clinical history and presentation of obstructive 
jaundice.  
 
 
• To study the various causes and sites of obstruction of the 
biliary tree.  
 
 
• To study the different modalities of treatment of obstructive 
jaundice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
 
 
 
Jaundice is a generic term, which describes yellow pigmentation of the 
skin, mucus membrane or sclera. 
 
Mention of jaundice is made in the works of Hippocrates (400 BC) who 
pointed out that persistent jaundice may be due to cancer or cirrhosis of liver.3 
Gallstones have been described in Chilean mummies since the second and third 
centuries AD. Galen in second century AD in his humoral concept of disease 
attributed abnormalities of yellow bile, black bile, blood and phlegma within 
the body to cause disease.3,4 
 
 
• Francis Glisson (1640), Abrahmson vater (1720) and Ruggero Oddi 
(1887) refined anatomy with description of sphincteric mechanism.3,4  
 
• Charcot (1877), discussed the symptoms associated with the passage of 
CBD stones which were jaundice, pain abdomen and fever (Charcot 
triad).  
 
• Telfer Reynold added hypotension and altered mental status to Charcot’s 
triad (Reynold’s Pentad) related to sepsis with cholangitis.5  
 
• Langenbunch performed first cholecystectomy in the year 1882.  
 
• Robert Abbe (1889) was the first to perform choledochotomy.  
 
• Lawson Trait performed choledocholithotomy.  
 
• Ludwig Courvoisier (1843-1918) stated Courvoisier’s law.3  
 
  
 
Courvoisier’s law: In obstruction of the common bile duct due to a stone, 
distension of the gall bladder seldom occurs, the organ usually is already 
shriveled.  
• William Stewart Halstead performed choledochoduodenal anastomosis 
• Emil Theoder Kocher’s introduced kocher’s incision and kocher’s 
maneuver.5  
 
• Charles McBurney – Transduodenal choledochotomy.  
 
• Hans Kehr – Invented T-tube.3  
 
• John B. Murphy – Cholecystoenterostomy avoiding choledochotomy.  
 
 
• Fredrich discussed carcinoma of gallbladder and suggested the 
relationship between gall bladder stone and cancer.3  
 
• Graham Cole (1925) – Oral cholecystography  
 
• Mirrizzi (1931) – Intraoperative cholangiography.  
 
• Okuda (1973) – CHIBA needle for percutaneous transhepatic 
cholangiography.  
 
• Wildegans of Germany (1953) introduced modern choledochoscope.  
 
• Shore and Shore (1965) – Flexible choledochoscope.  
 
• Yamakawa (1975) – Percutaneous transhepatic cholangioscopy.  
 
• McCune and Oi (1970) – ERCP.  
 
• Kawai et al – Endoscopic papillotomy.  
 
• First laparoscopic CBD exploration by Philips Peterson. 
                                                  
 ANATOMY 
 
Development 
 
Liver develops from an endodermal bud that arises from the ventral 
aspect of the gut, at the point of junction between foregut and midgut. The bud 
enlarges and soon shows a division into: 
 
• Cranial part – Pars hepatica  
 
• Caudal part – Pars cystica  
 
1. Pars hepatica: divides into right and left parts each of which forms one 
lobe of the liver.  
2. Pars cystica: Gives origin to the gall bladder and to the cystic duct. The 
part of the hepatic bud proximal to the pars cystica forms the bile duct. 
Bile duct at first opens on the ventral aspect of the developing duodenum. 
But as a result of differential growth of the duodenal wall and as a result 
of the rotation of the duodenal loop, it comes to open on the dorso-medial 
aspect of the duodenum along with the ventral pancreatic bud.6,7,8  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1: Development of liver and extrahepatic biliary apparatus 
 Anomalies of the extrahepatic duct system 
 
A. Abnormal length: Variation in the level at which the various ducts join 
each other.  
B. Abnormal mode of termination  
 
• Cystic duct may join left side of the CHD  
 
• Cystic duct may end in the right hepatic duct  
 
• Cystic duct may pass anterior to the duodenum, before joining the 
CHD.  
 
• Bile duct opens into the pyloric, or even the cardiac end of the 
stomach.  
C. Atresia: Parts of the duct system and sometimes the whole of it may be 
absent.  
D. Duplication: Parts of duct system may be duplicated.8  
 
 
ANATOMY 
Liver is divided into two major portions, the right lobe and left lobe, 
which are respectively drained by right hepatic and left hepatic ducts. The right 
and left hepatic ducts converge at the liver hilus to constitute the common 
hepatic duct. Cystic duct joins common hepatic duct to form common bile duct. 
The common bile duct courses downwards and backwards anterior to portal 
vein and lateral to hepatic artery, in the porta hepatis. The common bile duct is 
divided into four parts: Supraduodenal, Retroduodenal, Paraduodenal and 
Intraduodenal. The retroduodenal portion of the common bile duct approaches 
the second portion of duodenum obliquely accompanied by the terminal part of 
duct of Wirsung and opens in the duodenum at papilla of vater.6,z
  
 
 
 
 
 
 
 
Fig 2: Anatomy of extrabiliary  
apparatus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Blood supply 
 
Gall bladder is supplied by cystic artery. The blood supply to the biliary 
ducts is derived from the hepatic, cystic and superior pancreaticoduodenal 
arteries. Veins drain directly into liver or form tributaries of the portal vein. 
Gastroduodenal branches to CBD runs on the side of CBD at 3 ‘0’ clock and 9 
‘0’ clock position. Retroportal artery from celiac plexus runs posterior to portal 
vein to supply post-aspect of CBD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3: Normal vascular anatomy 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                 (e)
 a). Accessory cystic arteries 
artery. 
b).Accessory cystic artery 
(c). Hepatic artery arising
(d).Accessory hepatic arteries arising from the coelic trunk and superior 
mesenteric  Arteries 
(e). Anterior transposition of right hepatic artery and cystic artery
(f). Recurrent (caterpillar hump) right hepatic artery.
 
 
                                                         
 
                                                          (f) 
     Fig 4: Vascular anomalies7,8 
 
– arising from right hepatic  
– arising from left hepatic artery.
 from superior mesenteric artery.
 
 
 
 
 
                         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
Fig 5: Accessory hepatic ducts 
 
a. Accessory hepatic ducts entering common hepatic duct.  
b. Accessory hepatic ducts entering gallbladder.  
c. Left-sided accessory hepatic duct.  
 
  
  
 
                                                              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6: Common duct anomalies 
 
 
                                              a.  Low fusion of right and left hepatic duct  
 
                                              b.Double common duct  
 
                                              c.  Fusion of right hepatic and cystic duct  
 
                                              d. Right hepatic duct draining into gallbladder  
 
 
 
 
 
 
 
 
 
 
 
 Fig 6: Common duct anomalies (cont’d)
 
e. Normal confluence of CBD and pancreatic duct 
 
f. Independent drainage of CBD and pancreatic duct 
g. Dominant santorini duct 
 
 
 
Nerve supply 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Consists of sympathetic and parasympathetic fibres passing in the hepatic 
plexus and being joined at the portahepatis by branches from the anterior vagal 
trunk. 
PHYSIOLOGY 
One of the major function liver is to secrete bile normally between 600 to 
1200 ml/day. 
Bile is secreted in two stages by the liver: 
 
• Initially bile is secreted by liver hepatocytes, which is rich in bile acids, 
cholesterol and other organic constituents, which flow into bile 
canaliculi.  
•               Next, the bile flows peripherally towards the interlobular septa, 
where the canaliculi empty into larger ducts, the hepatic duct and 
common bile duct and then to duodenum or to gall bladder through cystic 
duct.10,11,12  
                           
  
 
Composition of 
bile     
• Water → 97.5 gm/dl   
• Bile salts → 1.1 gm/dl   
• Bilirubin → 0.04 gm/dl   
• Cholesterol → 0.1 gm/dl   
• Fatty acids → 0.12 gm/dl   
• Lecithin → 0.04 gm/dl   
• Na → 145 mEq/L   
• K → 5 mEq/L   
• Ca → 5 mEq/L   
• Cl- → 100 mEq/L   
• HCO3- → 28 mEq/L   
Metabolism     
 
Hepatic metabolism of bilirubin occurs in three 
phases: 
(1) Uptake (2) Conjugation (3) Excretion 
 
 
 
 
 
                                                                                                               
 
 
 
 
 
 
 
 
Metabolism and Excretion of Bilirubin 
  
 
I. 
 
Reticuloendothelial system 
Destruction of senescent RBC 
80-85% 
Globin 
Hemoglobin 
Marrow destruction of maturing RBC Heme 
 
Heme 
oxygenase 
 
Liver turnover of heme 
 
Biliverdin 
 
 
Biliverdin 
 
Reductase 
 
Bilirubin 
 
II. 
Bilirubin + Albumin 
 
PLASMA 
 
Bilirubin 
 
 
 
Bilirubin + ligadin 
 
Glucuronyl transferase 
 
LIVER Bilirubin monoglucouronide 
 
Glucuronyl transferase 
 
 Bilirubin diglucouronide 
     
 Bile 
Intestine   Intestinal reabsorption 
 Urobilinogens 
Kidney   Urinary excretion 
 Fecal excretion 
 Surgical Jaundice 
A complete or partial obstruction of biliary 
flow can cause jaundice and this may be intra or 
extra hepatic. 
Causes of surgical jaundice classified into:13 
 
A. In the lumen of duct  
• Choledocholithiasis  
• Parasitic infestation due to: Hydatid 
disease, Ascariasis  
• Hemobilia  
 
B. In the wall of duct  
1. Congenital  
• Biliary atresia  
• Choledochal cyst  
 
2. Acquired  
• Papillary stenosis  
• Strictures  
 
 a. Post-traumatic  
 
b. Post-surgical  
Injuries  during cholecystectomy  
  Exploration of CBD  
  Pancreatic operation  
 Gastrectomy  
 Biliary enteric anastomosis  
 Operation on liver and portal vein 
 
c. Post-inflammatory strictures  Gallstones  
Chronic pancreatitis  
 Chronic duodenal ulcer 
Parasitic inflammation  
Recurrent pyogenic cholangitis  
  
  
d. Primary sclerosing cholangitis  
 
e. Following radiotherapy  
 
f. Mirrizzi’s syndrome  
 
 
3. Malignant causes  
• Ca Gall bladder  
 
• Cholangiocarcinoma  
 
• Ca of ampulla of vater  
 
C. Outside the wall  
1. Benign: Pseudocyst of pancreas  
 
2. Malignant:  
• Ca head of pancreas  
• Enlarged lymph nodes at portahepatitis  
• Periampullary Ca  
• Extra biliary malignancy 
  
PATHOPHYSIOLOGY OF BILIARY OBSTRUCTION 
 
Cholestasis is defined as the failure of normal bile to reach the 
duodenum. It is classified as: 
1. Extrahepatic cholestasis  
 
2. Intrahepatic cholestasis  
 
Intrahepatic cholestasis: No demonstrable obstruction to the major bile 
ducts. They are caused due to drugs, hepatitis, hormones, Primary biliary 
cirrhosis and septicaemia. 
         Extrahepatic cholestasis: encompasses conditions where there is 
physical obstruction to the bile ducts. The bile stasis in the duct radicals within 
the portal triads leads to proliferation of the epithelial lining cells. Eventually 
the canaliculi become distended with bile. Distended canaliculi ruptures, which 
lead to extravasation of bile, producing so, called bile lakes surrounded by 
injured or necrotic liver cells. Because stasis of bile predisposes to ascending 
bacterial infections, extrahepatic cholestasis may be complicated by cholangitis. 
Escherichia coli produce beta-glucuronidase, which may lead to deconjugation 
of bilirubin in bile. This may lead to the formation of primary common bile duct 
stones with a high bile pigment as contents. 
          If obstruction continues, the reticulin laid down in the periportal area 
matures to hard type, causing fibrosis around the bile duct, which may further 
aggravate the cholestasis.14,15 
 
Biochemical changes10,16 
 
Bilirubin 
 
Conjugated hyperbiliubinaemia is the classic biochemical feature of 
obstructive jaundice. Conjugated bilirubin is water-soluble and penetration to 
body fluids is high, thus producing more jaundice than unconjugated pigment. 
 
Alkaline phosphatase 
 
The level rises in cholestasis and to a lesser extent when liver cell are 
damaged. The mechanisms of the increase are complex. Hepatic synthesis of 
the alkaline phosphatase by the hepatocytes is increased and this depends on 
intact protein and RNA synthesis. 
 
Gamma glutamyl transpeptidase (GGT) 
 
Serum values are increased in cholestasis and hepatocellular diseases. 
Levels parallel serum alkaline phosphatase in cholestasis and may be used to 
confirm that a raised serum phosphatase is of hepatobiliary origin. It is also 
elevated in alcohol intake, pancreatitis, chronic lung disease, renal failure and 
congestive heart failure. 
  
 
                                                   
Protein synthesis 
 
The liver plays a central role in protein synthesis and albumin is 
quantitatively the most important of plasma protein formed by the liver. The  
long half-life of serum albumin (20 days) makes the serum albumin level a 
better indicator of severity and prognosis in cases of patients with chronic liver 
disease. Abnormalities in serum albumin levels may reflect not only problems 
in synthesis but also alterations in the rate of catabolism, dilution by expanded 
plasma volume or enhanced loss from the GIT and kidneys. The most important 
role of protein synthesis by the liver is in the maintenance of the normal blood 
coagulation process. 
 
Clotting factors 
 
Liver disease results in impaired coagulation. Normal action of the 
vitamin-K dependent coagulation factor proenzymes (factors II, VII, IX and X), 
as assessed by the one stage prothrombin time, depend on both intact hepatic 
synthesis and adequate intestinal absorption of vitamin K. In obstructive disease 
prolonged prothrombin time can be improved by parenteral administration of 
vitamin K. A peculiar pattern of abnormalities occurs in patients with severe 
liver dysfunction; which includes low plasma fibrinogen level, a prolonged 
prothrombin time, and a normal or prolonged partial thromboplastin time.
  
 
ETIOPATHOGENESIS 
 
In the lumen of duct 
A. Choledocholithiasis  
 
Nearly all calculi found in the common bile duct were originally formed 
in the gallbladder and migrate down the cystic duct into the common bile duct. 
Calculi in common bile duct can be divided into:15,17 
 
1. Primary common bile duct stones  
 
2. Secondary common bile duct stones  
 
 
 
1. Primary common bile duct stones18,19  
 
These stones are formed primarily in the CBD and do not originate from 
gallbladder. These are caused due to bile duct stasis or due to infection. Almost 
all calculi are pigment stones. They are solitary, ovoid, light brown in colour, 
soft and easily crushable. 
Disturbance in the flow of bile as well as introduction of infected 
material into the biliary tract, may be associated with previous operation that 
disturb the usual motility dynamics of the sphincter, such as sphincterotomy, 
sphincteroplasty and biliary enteric anastomosis and also condition that obstruct 
the flow of bile into duodenum such as sphincter fibrosis, chronic pancreatitis 
and periampullary duodenal diverticula can lead to stasis of bile resulting in bile 
duct calculi and infection of biliary system. 
 
 Secondary common bile duct stones  
 
Are those that have migrated into the biliary system from the gall 
bladder.  
 
 
3. Retained stones in common bile duct are those that present at some point 
in time following cholecystectomy with or without concomitant bile duct 
stone.  
B. Hemobilia  
Hemobilia is a rare cause of upper GI bleeding that most often results 
from blunt or penetrating hepatic injury, with fistula formation within the liver 
between a vascular structure and the biliary duct system. Jaundice occurs due to 
acute extrahepatic biliary obstruction owing to the blood clot formation in the 
common bile duct. Non-traumatic cause of hemobilia includes hepatic abscesses, 
choledocholithiasis or oriental cholangiohepatitis. 
 
C. Parasitic infestation of bile duct  
 
1. Ascariasis: It is the most common helminthic infestation of bile ducts, 
caused by Ascariasis lumbricoides. In the presence of massive duodenal 
infestation the worms can enter the biliary system.20  
2. Clonorchiasis: It is endemic to Asia and is caused by the liver fluke, 
clonorchis sinensis, which is transmitted by ingestion of infected raw  
 
 
 3. fish. The intrahepatic ducts are the natural habitat, where they cause 
obstruction, periductal inflammation and fibrosis.21  
 
4. Echinococcus granulosus (Hydatid cyst): It is the usual organism 
responsible for hydatid disease. Large cysts in the liver may compress the 
intrahepatic biliary radicals and rupture into the bile duct and may release 
daughter cysts causing obstructive jaundice and fibrotic change in the 
biliary tree.22  
 
In the wall of duct 
 
1. CONGENITAL  
 
a. Biliary atresia  
 
The occurrence of biliary atresia is embryological. Failure of 
vacuolization of the solid embryonic bile ducts filled by proliferating 
epithelial cells was supposed to produce this malformation. Probably 
only a small percentage of cases are congenital malformations or 
intrauterine catastrophies.23  
 
Types 
 
Type I: Atresia of CBD, with a common hepatic duct remnant. 
 
Type II: Atresia of common hepatic duct and bile duct with right and left   
                     Duct remnants   
Type III: Atresia of the extrahepatic ductal system. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7: Types of extrahepatic biliary atresia 
 
b. Choledochal cyst24,25  
 
 
It is defined as an isolated or combined congenital dilatation of the 
extrahepatic and intrahepatic biliary tree.Three theories have been stated for the 
formation of the cyst. 
 
• Anomalous pancreatic duct and biliary duct junction – causes 
pancreatic reflux into common bile duct, leading to high-pressure in 
common bile duct.  
 
• Abnormal canalization of the bile duct during embryogenesis, with 
distal obstruction causing weakening of bile duct wall.  
 
• Abnormality of autonomic innervation of the extrahepatic tree.  
  
  
 
Caroli’s Disease 
 
It is a rare, congenital, non-familial condition, characterized by multiple 
sacular dilatation of intrahepatic ducts separated by segments of normal or 
stenotic ducts. Usually associated with congenital hepatic fibrosis, medullary 
sponge kidney, cholangiocarcinoma and stone formation.24,25 
Todani’s Classification of Choledochal Cysts 
 
Type I – Dilatation of the extra-hepatic biliary tree, a-cystic, bfocal, c-fusiform  
Type II- Saccular diverticulum of extrahepatic bile duct 
Type III- Biliary tree dilatation within the duodenum: choledochocele  
Type IVa- Dilatation of intra and extra-hepatic biliary tree 
 
Type IVb- Multiple extrahepatic cysts 
 
Type V- Dilatation of intrahepatic ducts (Caroli’s disease) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. Type I D.
C. Type IV a F. 
 
Fig 8: 
 Type II B. Type III E. Type IV
Type V     
Todani’s classification of Choledochal cysts
a  
 2. ACQUIRED  
 
Papillary stenosis: It has been defined as an obstructive disease of the 
papilla, which is organic and benign. It is usually primary, of unknown 
pathogenesis or secondary to inflammation such as duodenal ulcer or 
pancreatitis or passed out common bile duct calculi.26 
 
Benign biliary strictures 
 
Benign stenosis and strictures of the bile ducts occurs in number of 
conditions and may affect intrahepatic or extrahepatic biliary tree. 
Causes 
 
A. BILE DUCT INJURIES27-30  
 
I. Postoperative bile duct strictures  
 
1. Cholecystectomy and exploration of common bile duct  
 
2. Other operative procedures  
 
• Biliary enteric anastomosis  
 
• Operation of liver or portal vein  
 
• Pancreatic operation  
 
• Gastrectomy  
 
II. Stricture after blunt or penetrating injury  
 
B. POST-INFLAMMATORY STRICTURE WITH27,30  
 
1. Cholelithiasis/Choledocholithiasis  
 
2. Chronic pancreatitis  
 
3. Chronic duodenal ulcer  
 
 4. Abscess or inflammation in subhepatic region  
 
5. Parasitic infection  
 
6. Recurrent pyogenic cholangitis  
 
C. Primary Sclerosing Cholangitis  
 
D. Radiation-induced Cholangitis  
 
E. Papillary Stenosis  
 
Postoperative bile duct strictures 
 
The great majority of injuries to the bile duct occur during 
cholecystectomy with or without exploration of the CBD. They also occur in 
other operation on either the stomach, pancreas or liver or during surgeries for 
portal hypertension.32 
 
Number of factors relate to bile duct injury with cholecystectomy29-32 
 
A. Anatomical Variation  
 
There are wide anatomical variations in extrahepatic biliary tree and 
adjacent hepatic artery and portal venous structure. Anomalies of the vessels are 
in the tune of 20% and hence very common. The most common for right hepatic 
artery to arise in whole or in part from the superior mesenteric trunk. The 
important ductal anomalies are related to the manner of confluence of right and 
left hepatic ducts and of the cystic duct with the common hepatic duct and bile 
duct anomalies mentioned earlier. 
 B. Use of diathermy near Calot’s triangle.  
 
C. Technical factors: Bile duct injuries occur following 
cholecystectomy performed by surgeons who are 
inadequately trained or inexperienced. Traction on the 
gallbladder while applying clips on the cystic duct may 
include a part of the CBD wall which leads to stricture 
formation. The hepatic duct or common bile duct is often 
assumed as the cystic duct and has been excised.27  
 
D. Attempts to control haemorrhage during 
cholecystectomy: There may be damage to the bile duct if 
clamps are applied blindly.  
E. Bile duct ischaemia: Bile duct blood supply runs in three 
columns, one posterior and two lateral. It is suggested that 
damage to these vessels may result in ischaemia to the bile 
duct, with consequent necrosis and stricture.  
F. Pathological factor: Acute cholecystitis may be 
accompanied by extensive edema in the region of porta 
hepatitis and Calot’s triangle and there may be considerable 
friability during dissection.28  
  
 Primary sclerosing cholangitis 
 
It has an unknown etiology. It is a progressive cholestatic 
disorder characterized by a fibrosing inflammatory process, which  
affects the intrahepatic and or extrahepatic ducts. The strictures are 
typically short and annular alternating with normal or minimally 
dilated segments leading to characteristic beaded appearance.33,34 
  
 Classification of bile duct stricture 32(Bismuth Classification) 
 
Type I: Low common hepatic duct stricture; hepatic duct stump > 2 
cm. Type II: Mid common hepatic duct stump < 2 cm 
Type III: High stricture (Hilar) 
 
Type IV: Destruction of hilar confluence 
 
Type V: Involvement of sectoral right branch alone or with 
common duct 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 9: Classification of bile duct stricture 
  
 
 
III. Malignant causes  
 
a. Ca Gallbladder35,36  
 
This tumor represents only 2% of all cancers, but it is commonest site of 
cancer in biliary tract. 
Etiology 
75-98% of patients with gallbladder Ca has gallstones and also common 
in the presence of chronic cholecystitis. Others include Porcelain gallbladder 
(10-25% risk) Choledochal cyst, inflammatory bowel disease, polyposis coli 
and Primary sclerosing Cholangitis. 
Pathology 
85% of gallbladder carcinoma is adenocarcinoma, other variants common 
are mesenchymal tumors, carcinoid, lymphoma, squamous and adenosquamous 
carcinoma. 
  
  
TNM staging for gallbladder Ca 
 
 Tumor Nodes Metastasis 
    
Stage 0 Tis N0 M0 
    
Stage IA T1 N0 M0 
    
Stage IB T2 N0 M0 
    
Stage IIA T3 N0 M0 
    
Stage IIB T1-3 M0 M0 
    
Stage III T4 Any N M0 
    
Stage IV Any T Any N M1 
    
                                                   
 Tis: Ca in situ 
T1: Tumor limited to mucosa or muscularis 
 
T2: Tumor invades perimuscular connective tissue or serosa 
 
T3: Tumor invades liver (< 2 cm) or one adjacent organ. 
 
T4: Tumor extends > 2 cm into liver or two or more adjacent organ. 
 
Nevin classification for staging for gallbladder carcinoma37 
Depth of tumor 
Stage I: Mucosa 
 
Stage II: Muscularis 
 
Stage III: Serosa 
 
Stage IV: Liver invasion 
 
Stage V: Adjacent organ or distant metastasis 
 
 b. Cholangiocarcinoma38,39  
 
The incidence of bile duct tumors increases with age. Has even 
distribution between men and women. The most common is 
adenocarcinoma (95%) and remaining are squamous, leiomyosarcoma, 
mucoepidermosis, carcinoid and cystadenocarcinoma. 
 
 
Causes of cholangiocarcinoma are Primary sclerosing cholangitis, 
choledochal cyst, liver fluke infestation, CBD stone, thorotrast and 
asbestos exposure. 
 
TNM staging for Extrahepatic Cholangiocarcinoma40 
 
T1:    Tumor limited to mucosa/muscle 
 
T2:    Tumor invades periductal tissue 
 
T3:    Tumor invades adjacent structure 
  
 
 Tumor Nodes Metastasis 
    
Stage IA T1 N0 M0 
    
Stage IB T2 N0 M0 
    
Stage IIA T3 N0 M0 
    
Stage IIB T1-3 M0 M0 
    
Stage III T4 Any N M0 
    
Stage IV Any T Any N M1 
    
 
 
 
c. Periampullary carcinoma41  
 
Periampullary cancers include a group of malignant neoplasms arising at 
or near the ampulla of vater, within 2 cms of radius from ampulla. Most 
of them are adenocarcinoma arising from the head of pancreas (60%), 
ampulla of vater (20%), distal common bile duct (10%) or second 
part of duodenum (10%). 
 
Risk factors 41 
 
• Cigarette smoking  
• Diet – rich in animal fat  
• Chronic pancreatitis  
• Post Gastrectomy, cholecystectomy  
• Chemical exposure: naphthylamine, benzidine  
• Hereditary: Familial polyposis, Gardener’s syndrome  
 • Diabetes mellitus  
 
 
 
 
d. Ca head of pancreas43  
 
Accounts for 60% of periampullary carcinomas. Atleast 2/3rd of cases of  
 
pancreatic cancer arise in the head of the gland. Ductal carcinoma of the  
 
pancreas accounts for more than 90% of all malignant pancreatic exocrine  
 
tumours. Other variants are giant cell carcinoma, adenosquamous carcinoma,  
 
mucinous carcinoma and acinar cell carcinoma. 
 
Pancreatic cancer has a propensity for perineural invasion within and 
beyond the gland and for rapid lymphatic spread. The commonest sites for 
extralymphatic involvement are the liver, peritoneum and lungs. 
 
 
e. Carcinoma of Ampulla of Vater42 
 
Accounts for 20% of periampullary carcinomas. Most are 
adenocarcinomas. Though a number of other tumor histologies such as 
carcinoids, other neuroendocrine tumors and sarcomas may arise. Spread of the 
tumors is by local extension to involve the pancreas and duodenum and 
metastasis to regional lymph node. 
 
 
 
 
 
 
 
 
                                                  
 CLINICAL FEATURES44 
 
Abdominal pain 
 
Typically, the pain is felt in the right upper quadrant or epigastrium, with 
frequent radiation to the intrascapular area and typically lasts for 30 minutes to 
several hours. 
The pain due to bile duct obstruction is due to distension and increased pressure 
within the bile duct. With cholangitis both the pain and the initial phase of 
fullness and discomfort are produced at lower intraluminal pressure. 
It is inflammatory or malignant lesions spreads to the surface of the liver or gall 
bladder “somatic” pain results. 
Jaundice 
 
Jaundice is the abnormal accumulation of bilirubin in body tissue, which 
occurs when the serum bilirubin level exceeds 50 µmol/L. Excess bilirubin, 
causes a yellow tinting to the skin, sclera and mucous membranes. Jaundice is 
important feature of disease in the blood, liver or biliary system. 
Pruritus 
 
Pruritus is an important symptom of liver disease. It lasts longer than 3 to 
4 weeks regardless of the cause. It tends to be most marked on the extremities, 
is present less often on the trunk, rarely on the neck and face. It is often more 
troublesome after a hot bath and at night, when the skin is warm. The pruritis of 
liver disease has been attributed to the high plasma concentration of bile salts. 
  
Anorexia 
 
Anorexia is a common symptom of liver disease, particularly in 
jaundiced patients with either hepatocellular failure or biliary obstruction. 
Anorexia may be profound. Weight loss is probably due to anorexia and 
reduced food intake. 
Nausea, vomiting 
 
Nausea and vomiting is often a striking feature in patients with acute 
biliary obstruction but may not be present. 
Bowel functions 
 
A moderately increase in stool frequency with passage of soft or loose 
stools due to increased fecal fat resulting from a lowered intraluminal 
concentration of bile salts. It is an uncommon presenting symptom except in 
malignant biliary obstruction – steatorrhoea occurs with biliary obstruction but 
much higher level of fecal fat results when pancreatic duct is blocked. 
Stools and urine 
 
Fecal colour gives a good indication whether cholestasis is total, 
intermittent or decreasing. Occult blood in stools – sign of malignancy. 
Bile salts, deficient in the intestine in cholestasis are essential for the normal 
colour of the stools. It is usually pale in colour in cholestasis. 
 Urine is dark in colour in cholestatic jaundice because of increase in circulating 
conjugated bilirubin.  
  
Mass per abdomen – Gall bladder palpable or Courvosier’s gall bladder. 
 
Bleeding 
 
Patients may complain of spontaneous bleeding from the nose and gums or of 
easy bruising, because the prothrombin time is prolonged due to decrease in 
vitamin K absorption. 
Fever 
This is secondary to acute cholangitis, which results from two factors, 
obstruction of the biliary tree and bacteria in bile. 
General Physical Examination 
• A parous middle-aged obese female is a candidate for gallstones 
while chances for cancerous biliary obstruction increases with age.  
• Widely set eyes, a prominent forehead, flat nose and small chin are 
features of any form of persistent intrahepatic cholestasis in childhood.  
• Xanthoma and Xanthelesma around the eyes suggests chronic 
cholestasis. Elevated plasma cholesterol levels are seen as deposits in 
palmar creases, below the breast, chest or back. The tuberous lesions 
appear later and are found on extensor surfaces, especially the wrists, 
elbows, knees, ankles and buttocks.  
 
• Fever may be present in metastatic liver disease and with primary carcinoma of 
pancreas and stomach.  
  
• Dyspnoea and tachypnoea is commonly seen due to ascitis, abdominal 
organomegaly due to elevated and restricted movement of the diaphragm.  
 
• Jaundice: Yellowish discolouration of sclera, skin and mucous membrane due 
to increase in serum bilirubin above 2 mg/dl. Patients with prolonged biliary 
obstruction have a deep greenish hue compared with hemolytic jaundice where 
it is mild yellow and in hepatocellular jaundice where it is orange.  
 
• An increase in melanin pigmentation is seen with many chronic liver disease 
and chronic cholestatic disorders.  
 
• Scratch marks result from severe pruritus.  
 
 
• Spider naevi, excessive bruising, tiny petechial haemorrhages indicates the 
presence of chronic liver diseases.  
 
 
  
 INVESTIGATIONS 
 
 
 
Laboratory Examinations44-46 
 
1. Urine bilirubin  
When bilirubinuria is present the urine is unusually dark brown in colour. 
Test strips can detect as little as 1 to 2 µmol of bilirubin per litre. 
Bilirubinuria occurs even with small increase in plasma-conjugated 
bilirubin and usually precedes jaundice. 
Absence of bilirubinuria is important in a jaundiced patient, as it suggests 
an unconjugated hyperbilirubinemia or hemolysis. 
 
2. Urinary Urobilinogen  
Bilirubin esters entering the intestine undergo bacterial hydrolysis and 
degradation in the ileum and colon with the production of urobilinogen. Normal 
levels in the stools – 40 to 200 mg/24 hrs. 
Urinary urobilinogen give a reaction with Ehlirich’s aldehyde reagent.                       
A normal value is 0 to 4 mg/24 hrs. 
In the presence of liver damage more urobilinogen escapes hepatic 
uptake and biliary excretion and it is excreted in urine. 
  
 3. Liver Function Tests  
 
 
a. Serum bilirubin  
 
Normal values: Total - 
upto 1.2 mg/100 
ml 
 Direct - 
upto 0.4 mg/100 
ml 
 Indirect - 
0.4 to 0.8 mg/100 
ml 
 
 
 
The standard test for bilirubin is the Vandenberg reaction. The basis for 
this colorimetric test is the differing solubility of conjugated and unconjugated 
bilirubin..Hepatocellular disease impairs excretory function of bile to a greater 
degree than the ability to conjugate bilirubin and therefore the 
hyperbilirubinemia in this setting is predominantly of the conjugated type. It is 
very difficult to distinguish between hepatocellular disease and extrahepatic 
biliary obstruction solely on the basis of conjugated hyperbilirubinemia. 
In patients with jaundice secondary to extrahepatic obstruction, the 
determination of the direct fraction of bilirubin is more sensitive index than 
total bilirubin. 
  
 b. Alkaline Phosphatase  
 
Normal – 3 to 13 King Armstrong (K-A) units (Or)  
 
1.5 to 4 Bobansky units (or)  
 
     35 – 130 IU/L 
 
The level of alkaline phosphate rises in cholestasis and to a lesser extent 
when liver cells are damaged. 
The  rise  in  alkaline  phosphatase  along  with  increase  in  Gamma  
glutamyl transpeptidase is specific for hepatobiliary origin. 
 
c. Gamma Glutamyl Transpeptidase  
 
Serum values are increased in cholestasis and hepatocellular diseases. 
Levels parallel to serum alkaline phosphatase in cholestasis and may be 
used to confirm that a raised serum phosphatase is of hepatobiliary 
origin. 
d. Aminotransferases  
1. Serum Glutamic Oxaloacetic Transaminase (SGOT) or Aspartate 
Transaminase (AST)46  
This is a mitochondrial enzyme present in large quantities in heart, liver, 
skeletal muscles and kidney and the serum level increases whenever 
these tissues are acutely destroyed, presumably due to release from 
damaged cells. 
  
Normal: 
SGOT: 6-40 units 
(Karmen) 
 5-40IU/ml 
 0-15IM/ml 
 
The  rise  in  alkaline  phosphatase  along  with  increase  in  Gamma   
 
Normal: 
SGOT: 6-40 units 
(Karmen) 
 5-40IU/ml 
 0-15IM/ml 
 
2. Serum Glutamic Pyruvic Transaminase (SGPT) or Alanine 
Transaminase  
(ALT) 
This is a cytosolic enzyme also present in liver. Compared to SGOT major 
amount ispresent in liver. Therefore, this is more specific for liver damage than 
SGOT. 
  
 Normal: 
SGPT: 6-36 units 
(Karmen)
 0-15IM/ml 
 5-35IU/L 
   
3. Albumin: Normal – 35 to 50 g/L  
 
Synthesized in the hepatocytes. Its half-life is 15 to 20 days. 
Hypoalbuminaemia reflects severe liver damage and decrease albumin 
synthesis. Other causes for hypoalbuminaemia are: 
 
• Protein losing enteropathies  
 
• Nephrotic syndrome  
 
• Chronic infection  
 
4. Globulin: Normal – 5 to 15 g/L  
 
They are a group of protein mostly made up of gamma globulin, produced by 
B- lymphocytes. Alpha and beta globulin are produced in hepatocytes. Globulin 
increases inchronic liver disease. 
 
 
 
5. A/G ratio: 1.5-3/1. Any change or reversal in the ratio indicates liver damage.  
 
 
 
6. Prothrombin time: Normal – 12 to 16 seconds which collectively measures 
factors II, V, VII, and X. Biosynthesis of these depends on Vitamin K, 
 Prothrombin time may be elevated in hepatitis, cirrhosis and obstructive 
jaundice. Marked prolongation of prothrombin time > 5 sec above control is a 
poor prognostic factor.  
 
 
Radiological studies47-51 
 
 
1. Ultrasound  
 
Ultrasound examination of the hepatobiliary system is an important first line, 
non-invasive investigation. Patient preparation for ultrasound should include 
fasting for 12 hours. Dilated bile ducts, gall bladder disease, hepatic tumours 
and some diffuse hepatic abnormality are identified.48,49 
Normal ultrasound shows the liver to have mixed echogenicity. Portal and 
hepatic veins, inferior venacava and aorta are shown. Normal intrahepatic ducts 
measuring 1 to 3 mm in diameter and common bile duct 2 to 7 mm in diameter 
are seen on ultrasound. Ultrasound plays a vital role in the evaluation of focal 
liver disease, screening for liver metastasis, hepatocellular carcinoma, portal 
hypertension, surgical obstructive jaundice and hepatic veno-occlusive disease. 
Sonography is ideally suited to study the internal architecture of a focal mass 
and distinguish a solid from a cystic lesion. The addition of colour Doppler 
flow imaging further helps in characterizing mass lesions and assessing patency 
of vessels. The major drawback of this technique is that it is highly operator 
dependent. 
 2. Computed Tomography (CT)  
 
CT also shows dilated biliary ducts, thus helps to distinguish obstructive from 
non-obstructive jaundice in 90% of cases. Still as a screening procedure ,it does 
not have an advantage over ultrasound scan. It is however, more likely than 
ultrasound to show the level and cause of obstruction. 
 
 
Advancement of CT technology including the development spiral scanners and 
more recently, multi-detector row CT scanners and the development of three 
dimensional (3D) imaging software have significantly improved the ability of 
CT to image patients with obstructive biliopathy.52 
3. Endoscopic retrograde cholangiopancreatography (ERCP)  
 
With the help of ERCP, diseases which involve the oesophagus, stomach, 
duodenum, pancreas and the biliary system including duodenal diverticula and 
fistulae can be easily diagnosed.53 
 
 
ERCP is performed with a side viewing endoscope, either video or fibre-optic. 
The stomach and duodenum are visualized and biopsy or cytology specimen 
taken if necessary. The papilla is visualised. The cannula is then introduced 
under vision into the papilla and then contrast is injected under fluoroscopic 
guidance. X-ray films are taken. The success rate of ERCP is about 80 to 90%, 
but depends on expertise.54 
Indication 
  
• Used to show duct strictures  
 
• Gall bladder and CBD stones  
 
• Pancreatic and bile juice may be obtained for culture, aspiration cytology  
 
• After biliary surgery  
 
• Pancreatic disease  
 
• Cytology or biopsy from malignant growth or strictures  
 
Complication 
 
• Acute pancreatitis  
 
• Cholangitis  
 
4. Percutaneous transhepatic cholangiography  
 
Contrast is injected percutaneously into a bile duct within the liver. The 
procedure is done under radiological guidance. The “skinny” chiba needle is 22 
G, is introduced in the 7th, 8th, or 9th right intercostal space at mid axillary line, 
with the help of USG & the contrast is injected. Biliary tree is identified and if 
any dilated ducts are visualized, they should be catheterized and external or 
internal biliary drainage  should be established.55 
 
The technique is easy to perform and the success rate is 100% if intrahepatic 
bile ducts are dilated. 
  
 Indications 
• When ERCP has failed.  
 
• Endoscopic access is difficult (Hepaticoenterostomy, Billroth II).  
 
• Brush cytology and biliary biopsy can be done.  
 
Complication 
 
• Bleeding  
 
• Biliary peritonitis  
 
• Septicaemia  
 
 
 
 
           
5. Magnetic resonance cholangiopancreatography (MRCP)56,57  
MRCP reveals water containing bile and pancreatic juice within bile duct and 
pancreatic duct without injection of contrast. MRCP is more expensive than 
USG and CT, and is not available in all hospital. 
       It has an overall accuracy of greater than 90% in showing CBD duct stones 
 
6. Endoscopic ultrasound (EU)58  
 
This is  an endoscope with a miniature ultrasound transducer  
 
mounted at its tip. Most endoscopes used for ultrasonography have a 
mechanical rotating scanner at the tip and are side or oblique viewing. 
Recognizing the structures seen at endoscopic ultrasonography requires 
adequate period of training and so has limited its availability to specialist 
 centres. 
In the hepatobiliary system its main role is in the detection  of pancreatic 
tumours. It also detects CBD stones and can be used for image-directed biopsy. 
Accuracy of endoscopic ultrasound for choledocholithiasis is more than 90%. 
 
7. Biliary scintigraphy59  
 
The technetium-labelled iminodiacetic acid derivative (IDA) is cleared from the 
blood by hepatocellular organic anion transport and excreted via bile. The 
method is used to determine patency of the cystic duct in cases of acute 
cholecystitis. The gall bladder ejection fraction can be calculated. 
Cholescintigraphy can identify whether the bile duct is obstructed. Scintigraphy 
is also used in determining the patency of biliary-enteric anastomosis and can 
also show biliary leaks after cholecystectomy or liver transplantation. 
 
8. Operative and postoperative cholangiography60  
 
They are indicated when there is stones present in common bile duct. After 
exploration of the CBD, cholangiography should  be performed, using high 
kilovolt peak technique and full strength contrast. 
Any debris may cause filling defects less sharply defined than those caused by 
gallstones. If there is any obstruction of the CBD, there will be no flow contrast 
into the duodenum. Postoperative cholangiography using contrast injected 
 gently should be done routinely before  removal of a T-tube draining the biliary 
system. It is essential to obtain filling of all right and left intrahepatic radicals, 
the common hepatic duct and common bile duct and flow to duodenum before 
removal of T-tube.With the development of newer investigative modalities, the 
remaining tests mentioned, are rarely done nowadays for the diagnosis of 
obstructive jaundice. 
 
9. Abdominal Radiograph  
The abdominal radiograph may be performed as part of the initial surgical 
evaluation of the patient presenting with an abdominal condition. 
10 to 15% of gallstones will be visualized by this examination.  
Gas in biliary tree (Aerobilia) may be seen after endoscopic sphincterotomy or 
bile duct or bowel anastomosis.  
10.Barium contrast upper gastrointestinal X-ray  
 
X-rays can distinguish between a neoplastic and calculus obstruction. Early 
changes in malignancy include short thick mucosal folds in duodenum with 
relative stasis. The circumscribed filling defect in the gastric silhouette 
described as PAD SIGN, the post-bulbar impression of duodenum due to a 
dilated common duct in Ca pancreas. The reversed “3 sign” of Frostberg in 
periampullary carcinoma are all important radiological signs of malignancy. 
  
11. Oral Cholecystography  
Agent used usually is Iopanoic acid. The material is transported in the blood 
bound to albumin and selectively taken up by the liver, where it is conjugated 
and excreted as theglucuronide of Iopanoic acid. The contrast material then 
enters the gall bladder and is concentrated there. Gallstones detected in most of 
the patients and anomalies of gallbladder visualized. 
Non-visualization of gall bladder has numerous causes including failure to 
ingest the agent, intestinal obstruction preventing passage through the small 
bowel, malabsorption, liver dysfunction and biliary tract abnormalities 
preventing flow of contrast into the gall bladder. 
12. Intravenous cholangiography  
 
From the time of its development in 1953 until recently, intravenous 
cholangiography using sodium or meglumine iodipamide has been regarded as 
an important technology for examination of the biliary tree. It has been reported 
that the common duct will be visualized in 90% of patients with normal levels 
of bilirubin. Problems with this procedure include faint visualization, morbidity 
and mortality associated with the contrast agent and non-visualization in the 
jaundiced patient. 
 
 
 Despite these problems, it has been a widely used procedure especially 
for evaluating the patient who has undergone cholecystectomy for biliary leak. 
As the error rate is rather high and there are other imaging technique that 
offer better visualization of biliary tree the value of intravenous 
cholangiography is doubtful. 
  
 Preoperative preparation 
 
• Obesity increases the technical difficulties for the surgeon and makes 
post-operative complications more likely. 
 
• Use of contraceptive pills adds the risk of venous thrombosis and it is 
advisable that OCP be stopped prior to and after 6 weeks of surgery.  
 
• An abnormal prothrombin activity increases the risk of haemorrhage. 
Administration of Vitamin K dose will reduce this risk.   
• Insertion of Nasogastric tube, intravenous fluid infusion and urinary 
catheter to monitor output is a must.  
• Nutritional status should be assessed and improved if necessary.  
• The renal, cardiovascular system and CNS should be evaluated before 
surgery.  
• Jaundice patient have a high-risk of postoperative renal failure which can 
be reduced by operating during diuresis produced by Mannitol with fluid 
supplementation.  
• Anaesthesia 
General anaesthesia for biliary tract surgery is essentially no different 
from that of any intraabdominal operation. However, there are a few points of 
particular interest to the anaesthetist. 
 
• The presence of abnormal liver function tests requires caution to be taken 
according to the degree of abnormality with the dosage of all drugs used, as 
 almost all depend on the liver for their detoxication. Halothane is 
contraindicated in the presence of abnormal liver function.  
• General anaesthesia must produce sleep, analgesic, good muscle relaxation 
and stable blood pressure. Care must also be taken during the operation to 
avoid kinking of inferior vena cava during deep retraction which results in 
drop in cardiac output. Intravenous atropine 0.6 mg given first before the 
operative cholangiogram helps to diminish any spasm of the sphincter of oddi.  
Position of patient 
 
Patient is placed on the cassette tabletop. Patient is placed supine with a 
foam pillow is inserted under the ankles to raise the calves off the table. 
Another foam pillow is inserted at back of the patient to elevate the gall bladder 
bed. 
Incision 
• Kocher’s right subcostal  
 
• Midline incision  
 
• Right upper paramedian  
 
  
 Surgical procedures 
 
In current surgical practice, various operative procedures have been performed 
for obstructive jaundice, depending on the cause. The choice of procedure also 
depends on the experience and preference of the surgeon. 
 
• Cholecystectomy with common bile duct exploration with stone 
removal/dilatation/sphincteroplasty and T-tube drainage.  
 
• Cholecystectomy with Choledochoduodenectomy with T-tube drainage. 
• Cholecystojejunostomy  
 
 
• Pancreaticoduodenectomy (Whipple’s procedure)  
 
• Palliative operation for relieving obstructive jaundice due to malignant 
disease.  
 
• Pancreaticojejunostomy  
 
• Non-surgical biliary drainage  
 
• Different operations for biliary stricture  
 
 
A. Exploration of the common bile duct61,62  
 
The operation of choledochotomy carries a mortality of atleast four times 
greater than cholecystectomy alone. 
 
Indications 
 
• History of jaundice  
  
• Multiple small stones or Single faceted stone in the gall bladder  
 
• A dilated cystic duct  
 
• Induration of head of the pancreas  
 
• Dilated common duct – more than 8 mm  
 
• A palpable stone in the common bile duct during surgery.  
 
Operation 
 
Opening of the duct 
 
Stay sutures of catgut are inserted into the common duct near either side 
of the anterior aspect about 2 cm above the first part of the duodenum and a 
longitudinal incision is made with a fine knife. 
 
Exploration (Distal) 
 
Fogarty catheter is inserted down the common bile duct into the 
duodenum and the balloon inflated. The catheter is gently withdrawn until it is 
halted by the sphincter of Oddi. The lower end of the duct is palpated and stone 
felt against the catheter, above the balloon. A bulldog clamp is placed across the 
common duct above the opening to prevent any stones escaping into the 
proximal ducts. The balloon is deflated and the catheter gently brought through 
the sphincter this can be traced by the palpating fingers. The balloon is 
reinflated and steadily withdrawn bringing the stone with it. This procedure is 
repeated until no more stones are withdrawn. 
  
Exploration (Proximal) 
 
The catheter is reinserted into the proximal segment and the procedure is 
repeated in the left and right hepatic ducts. The bulldog clip is placed on the 
common duct below the opening to prevent stones falling into the distal duct. 
The balloon is inflated until some resistance is felt and withdrawn with the 
pressure maintained on the syringe. This is necessary because the lumen of the 
duct increases in diameter and unless the balloon continues to fill the lumen, a 
stone may slip past. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 11: Exploration of the common duct
 
 
 
Assessment by X-ray
 
The catheter is 
distal to the opening where it is initiated to occlude the duct. After checking the 
position of the x-ray machine, about 10 ml of hypaque is injected and films are 
taken. The balloon is deflated a
the common hepatic duct. For fixed stone bougie’s or Desjardin’s forceps are 
used to dislodge the stone and withdrawn.
Closure of the duct can be done with or without a T
 
 
inserted into the common duct so that the balloon lies just 
nd the procedure repeated with the catheter in 
 
-tube. Catgut is used 
 and usually it is continuous. 
Gall bladder is removed, cystic duct, cystic artery ligatures are checked. Any 
bile leak from the common bile duct is inspected. 
 
Removal of T-tube postoperatively60 
 
The t-tube is allowed to drain freely into a bile bag for 5 days when it is 
clipped for 1 hour after meals. This is increased by 1 hour each day so that by 
the tenth day the tube is clipped all day. A T-tube cholangiogram is obtained as 
a final check that the duct system is normal and if so the skin suture is 
withdrawn and the tube removed. 
 
D. Sphincterotomy63  
 
Sphincterotomy requires duodenotomy placed at the level of the 
sphincter of Oddi, division of the sphincter and suture of the wall of 
common bile duct to the duodenum. It has advantages of facilitating 
inspection of the papilla, biopsy and pancreatic radiography, if required. 
 
 
Indication 
 
• Common bile duct stone  
 
• Stricture at the lower end of the common bile duct  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E. Exploratory choledochoscopy
 
The choledoscope permits visual inspection within the bile ducts 
during surgical exploration for gallstones and may greatly facilitate 
the exploration of the common and hepatic bile ducts and the 
localisation and retrieval of stones.
 
Position of patient 
 
The operating table should have facilities for x
operative cholangiography to be done. The patient should be positioned with 
a few degrees of feet down and lateral tilt to the right.
Fig 12: Sphincterotomy 
64
  
 
-ray to enable the 
 
  
Incision 
 
 
A transverse right upper abdominal incision. 
Operation 
 
Once the abdomen is opened, the duodenum and the hepatic flexure of 
the colon are retracted downwards. A clear exposure of anterior aspect of the 
supraduodenal common bile duct is done. The choledochotomy should be 
placed as low as possible, above the superior border of the duodenum. 
The choledochoscope is introduced into the common bile duct in a 
distal direction. The interior of the common bile duct is inspected as the 
instrument is advanced distally. A gallstone may be retrieved from the 
common bile duct under direct vision. A fine balloon catheter (Fogarty) is 
passed down the channel of the choledochoscope and passed beyond the 
stone and inflated. The balloon, stone and instrument all withdrawn together. 
For multiple mobile stones in the duct a retractable wire basket may 
be passed down the choledochoscope channel. The basket should be used to 
open as a dragnet to avoid crushing of the stones. 
Proximal choledochoscopy is done to view hepatic ducts. 
Choledochotomy is closed with 3/0 catgut, either interrupted or continuous. 
  
  
F. Transduodenal exploration of the bile duct (Biliary 
Sphincterotomy)63  
Indication 
• Impacted stone to the lower end of the common bile duct.  
• Stenosis of the papilla and sphincter  
• Re-exploration  
 
 
 
Contraindication 
 
• A single large stone in the supraduodenal portion of the common bile 
duct that does not descend to the sphincteric region.  
 
• Multiple facetted stones locked in the bile duct.  
 
• Long stricture of terminal common bile duct  
 
• Presence of acute pancreatitis.  
 
 
 
 
 
 
Operation 
 
Either a right paramedian or Kocher’s subcostal incision provides 
good access to the biliary tree once the abdomen is opened, the hepatic 
flexure of the colon and proximal transverse colon are mobilized and 
reflected caudally exposing the head of the pancreas and the duodenal.Head 
of the pancreas and duodenum are mobilized forward and medially. 
Dissection continues until the aorta is visualized and the third part of the  
  
duodenum is free. Papilla is located on the medial wall of the 
duodenum. A small bulldog clip is then placed across the supraduodenal part 
of the common bile duct in order to prevent calculi slipping back into the 
common hepatic duct and its tributaries.The duodenal walls are incised 
longitudinally or transversely. Babcock tissue forceps are applied to the 
longitudinal fold, distal to the papilla and the latter is drawn into 
 
duodenotomy incision. A grooved director or lacrimal probe is passed into 
the papillary orifice and hence into the common bile duct. 
Sphincterotomy is done at 10’0 clock position. Stones are extracted 
with Desjardins forceps and Fogarty balloon catheters. Clearance of the duct 
is confirmed by intraoperative post-exploratory cholangiography. 
Alternatively, choledochoscopy may be used. The duodenotomy is 
closed in its original axis using a continuous suture (catgut) and fine non-
absorbable Lambert suture. 
 
Complication 
 
Bleeding: Persistent bleeding of the sphincterotomy incision usually 
occurs from a divided circumferential duodenal artery which is best secured 
by suture. 
  
  
Cholangitis: It is important to remove all calculi and provide an adequate 
sphincterotomy with free drainage. 
 
Acute pancreatitis: Probing into pancreatic duct should be avoided and to 
ensure that no suture encircle the pancreatic duct 
 
G. Duodenoscopic sphincterotomy for removal of duct stones65,66  
Fibreoptic oesophagogastroduodenoscopy is now a routine procedure. ERCP 
is performed by passing a Teflon catheter through the biopsy channel of the 
duodenoscope and placing it directly in the orifice of the papilla of vater 
under direct vision. Contrast material is then injected during fluoroscopy and 
appropriate radiographs are taken. The technique is performed under 
sedation. 
 
Sphincterotomy 
 
After endoscopic cholangiogram has demonstrated stones, the Teflon 
catheter is replaced in the distal bile duct by a diathermy wire. 
 
After confirming its position radiographically the wire is withdrawn 
slightly and made taut to produce a bow, pressing on the root of the papilla. 
  
  
Diathermy current is applied to produce a cut 15-20 mm long. The  aim is to 
ablate the biliary sphincters and a view directly up the bile duct is obtained. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 13: Duodenoscopic sphincterotomy 
 
Stone extraction 
 
After sphincterotomy, some allow stones to pass spontaneously (< 1 cm in 
diameter). Few prefer to remove all stones using balloon catheters or wire 
basket. 
omplication 
 
• Bleeding (mainly from the sphincterotomy site)  
 
• Cholangitis  
 
• Pancreatitis  
 
• Retroperitoneal perforation  
 
 
 
 Endoscopic treatment for patients without stones 
 
Patient with convincing biliary symptoms following biliary surgery 
are suspected to have sphincter of Oddi dysfunction or stenosis; this may 
result from the passage of stones or instrumentation. 
 
Endoscopical sphincterotomy is a logical and effective form of 
treatment when functional obstruction is present. 
For malignant biliary obstruction, when the patient unfit or unsuitable 
for surgery, jaundice can be relieved by performing sphincterotomy through 
the tumour or by placing a prosthetic stent. 
 
 
 
Palliative operations for jaundice due to malignant disease67,68 
 
Indications 
 
Non-resectable carcinoma of the pancreas and peri-ampullary 
carcinoma 
 
Two symptoms are readily palliated by operation: duodenal 
obstruction and jaundice. 
 
For duodenal obstruction gastroenterostomy with entero-enterostomy 
is done. 
  
  
 
 
 
For jaundice 
 
a. Cholecysto-enterostomy  
 
Indication: Tumour must atleast be 5 cms below the junction between 
the cystic duct and the common bile duct. 
 
 
Procedure 
 
• Gall bladder emptied using a trocar suction apparatus.  
 
• Jejunal loop is laid alongside the gall bladder of 
cholecystoenterostomy done using 2/0 catgut.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 14: Cholecystojejunostomy 
  
  
 
b. Choledochojejunostomy 
 
Indication 
 
• Distal common bile duct malignant stricture  
 
• Malignant growth distal common bile duct/Peri-ampullary carcinoma  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
End-to-side anastomosis 
 
The common duct is dissected free and transected, and the distal end 
is oversewn. The proximal end is then sutured to the loop of jejunum. The 
opening in the jejunal loop, made at the apex should be a little smaller than 
the diameter of the common duct. 
Anastomosis can be completed with or without T-tube. 
 
 
  
  
 
 
 
 
 
Side-to-side anastomosis 
 
If the bulk of the jejunum allows, then a series of accurate interrupted 
all coats sutures is placed between the opening of the common duct and the 
opening in the jejunum. Anastomosis completed with or without T-tube. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 15: End to side Fig 16: Side to side 
 
Choledochojejunostomy                                      Choledochojejunostomy 
 
 
 
  
  
 
 
Choledochoduodenostomy69  
 
Indication 
 
• Dilated common bile duct containing infected bile and biliary sludge.  
 
• Multiple intrahepatic stones  
 
• Suppurative cholangiohepatitis  
 
Contraindication 
 
• In patient with a bile duct of normal dimension.  
 
 
 
Operation 
 
Incision: Kocher or Paramedian 
 
Exposure: First and second parts of duodenum with addition of the 
lesser sac and the free edge of the lesser omentum and the liver. 
Dissection 
 
The common bile duct is then opened and a specimen of bile sent for 
culture. Stones are removed and the duct is cleared by copious lavage with 
saline. The duodenum is freely mobilized by Kocher’s maneuver in order to 
allow it to roll upwards over the anterior surface of the bile duct. 
After the duct has been dissected a vertical incision 2-5 cm long is 
made on its supraduodenal portion and the duodenum is opened in such a 
way to allow the stoma to be made without tension. The anastomosis is done 
with interrupted 3/0 chromic catgut. 
  
I. Benign biliary stricture
 
Diagnosis and Principles of treatment
 
Damage to the bile duct may be recognized immediately (at 
operation), earlypostoperative period or late after discharge.
 
 
Immediate repair of bile duct injury
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 17: Immediate repair of bile duct injury
 
The form of repair will depend upon the severity and site of the 
damage, but results
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 are excellent. 
 
 
  
 
a. Common duct laceration without tissue loss  
 
Insertion of T-tube through the laceration and closure of the wound 
with interrupted absorbable sutures. T-tube is removed after 10 days, 
after cholangiogram. 
 
 
 
b. Common duct laceration with minimum tissue loss  
 
Loss of part of the wall of common duct occurs when the cystic duct 
is torn at its origin. Its tissue loss is minimal; the edges are trimmed 
and closed transversely. T-tube is positioned in common bile duct 
through a separate incision and removed after four weeks. 
 
C. Common duct divided  
 
 
 
End-to-end anastomosis 
 
A clear division of common duct without tissue loss may be repaired 
by direct anastomosis at the two ends with interrupted sutures over a T-tube, 
which should be left in situ for three months. 
 
Biliary intestinal anastomosis 
 
Accidental removal of a whole segment of common bile duct will 
necessitate some form of biliary-intestinal anastomosis using a Roux loop at 
jejunum. 
  
  
                               Late repair of bile duct stricture 
 
1. Biliary intestinal anastomosis for low bile duct strictures  
 
Treatment of a stricture at the lower end of the common bile duct will 
depend upon its site and relationship to the ampulla. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 18: Biliary intestinal anastomosis for late repair of bile duct 
stricture 
 
 
 
 
 
a. Choledochoduodenostomy  
 
To avoid leaving an undrained sump the common duct above the 
stricture is anastomosed side-to-side to the second part of the 
duodenum establishing a wide stoma.Choledochojejunostomy  
  
Anastomosis of the common duct to a jejunal Roux-en-Y is 
theoretically more desirable because food particles are less likely to enter 
biliary tree and obstruct its lumen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 19: Biliary intestinal anastomosis for low bile duct 
injuries 
 
 
 
Biliary intestinal anastomosis for mid duct strictures 
 
Anastomosis of dilated common hepatic duct above the stricture to a 
jejunal Roux-en-Y loop using interrupted catgut. A T-tube inserted into the 
common hepatic duct with one arm through the anastomosis should remain 
in situ for three months. 
  
  
 
Biliary-intestinal anastomosis for high duct stricture 
• The track, which will lead to the mucosa-lined ducts, is first explored 
with a fine probe, it is then enlarged with Baker’s dilators.  
 
• Once a mucosa-lined duct has been identified a rubber catheter is 
positioned and cholangiogram performed.   
 
 
• Positioning of a transhepatic tube: Fully curved Randall’s forceps 
are now inserted into the common hepatic ducts and passed along the 
dilated intrahepatic duct system, usually of the left lobe and then to 
the periphery. Then tip of forceps grasp the end of the latex rubber 
tube and is drawn along the ducts to appear at the porta hepatitis.  
 
• Construction of Roux loop and exposure of the jejunal mucosa: A 
standard ante-colic jejunal Roux-en-Y is fashioned and the end of the 
free limb closed in two layers. Just proximal to this closed end a 2 cm 
diameter disc of seromuscular wall is removed to expose the intact 
jejunal mucosa.  
 
 
 • The end of the transhepatic tube passed to the jejunal lumen and 
anchored.  
• Traction on the transhepatic tube from above will draw the mucosa, 
into the lumen of the common duct to create sutureless anastomosis 
with mucosa-to-mucosa opposition.  
 
• Few interrupted catgut sutures are inserted between the jejunal serosa 
and liver capsule to maintain the graft in position.  
 
• The upper end of the transhepatic tube is brought out through a 
separate stab incision in the abdominal wall and fixed securely to the 
skin with non-absorbable suture.  
 
 
Bilateral mucosal grafts 
 
For very high stricture involve the carina or the right and left ducts 
individually. In this event both ducts intubated and the transhepatic tubes 
inserted separately through the exposed jejunal mucosa to create an 
epithelial bridge between the two ducts. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    
 
     Fig 20: Mucosal graft for repair of bile duct 
 
Management of the transhepatic tube and vacuum drain 
 
• First 3 postoperative days – low-pressure suction (Robert’s pump at 5 
cm Hg).  
 
• Later replaced by plastic bag into which bile drains freely.  
 
• On the tenth day cholangiogram to confirm patency of the 
anastomosis.  
 
• End of the transhepatic duct closed with a spigot.  
 
• Patients are taught to irrigate the tube daily with 20 ml sterile water to 
maintain patency.  
• Three months later the transhepatic tube is removed.  
 
 J. Alternative methods of biliary decompression  
 
1. Intrahepatic cholangiojejunostomy (long wire operation): Involves 
the anastomosis of an exposed peripheral intrahepatic duct to a 
defunctional limb of jejunum.  
 
2. Percutaneous transhepatic drainage.  
 
 
Malignant biliary stricture70 
 
Proximal tumours 
 
• Hepatic bifurcation tumours  
 
• Hepatic duct tumours  
 
a. Parts to be excised are (radical excision)  
 
• Gall bladder  
 
• Entire supraduodenal common hepatic duct system as far as the right 
and left hepatic ducts. 
 
b. Join the several hepatic duct openings for two biliary enteric 
anastomosis  
 
c. Silastic drains through the substance of liver is brought to the inferior 
surface of the liver.  
d. Roux-en-Y loop is constructed and sutured to the jejunum with silastic 
tube inside (internal) and the other end brought outside the abdominal 
wall. The tubes are removed after 2-3 months after cholangiogram.  
 
 
 
  
Distal tumours 
 
Tumours of  the  bile  duct  below  the  cystic  duct  are  treated  with 
 
pancreaticoduodenectomy. 
 
• Whipple’s surgery  
 
• Pylorus preserving pancreaticoduodenectomy  
 
• Total pancreatectomy  
 
 
 
Non-surgical biliary drainage 
 
• External drainage  
 
• Internal drainage  
 
 
 
External drainage 
 
Indications 
 
• Drainage done preoperatively to reduce operative mortality and 
morbidity, especially acute renal failure.  
 
• Incase of acute cholangitis because later surgery is expected to be 
safer.  
 
• For patients who are inoperable, long term drainage being performed 
to relieve symptoms of cholestasis.  
  
  
Prerequisite 
 
• Intrahepatic ducts have to be dilated.  
 
• Coagulation studies should be normal.  
 
• Lateral X-ray screening facilities available.  
  
                                                        
                                                   
Procedure 
 
As  per  percutaneous  transhepatic  cholangiogram  and  then  a  stent  
is  left (j=shaped / pig-tailed catheter placed)  for decompression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 21: Non-surgical biliary drainage 
 
 
 
 
 
  
 
 
Internal drainage 
 
• ERCP and stenting – explained earlier.  
 
• PTC where the guide wire is passed beyond the stricture and then the 
stent passed. After the insertion of the stent through the stricture, 
guide wire removed allowing internal decompression of the 
cholestasis.  
 
• Palliative operation for jaundice due to malignant disease.  
 
 
 
 
 
                                                    
 
Pancreatoduodenectomy (Whipple’s Operation) 
 
The purpose of the operation of pancreatoduodenectomy is to remove the 
tumour en bloc with adjacent lymph nodes. The head of the pancreas, the 
duodenum, the pylorus and distal half of stomach, the gallbladder and the 
lower end of the common duct and to restore biliary-pancreatic and 
gastrointestinal continuity. 
Pancreatoduodenectomy is the treatment of choice for operable malignant 
tumours of the ampulla of vater, the lower end of the common bile duct, 
the duodenum and the periampullary region of the head of the pancreas. 
  
  
Incision 
• Right Mayo-Robson  
• Bilateral subcostal incision  
 
Procedure 
I. Retraction of common bile duct: Exposure and ligation of right 
gastric and gastroduodenal arteries.  
II. Finger dissection between pancreas and portal vein from above and 
finger dissection between pancreas and superior mesenteric vein 
from below. If both index finger meet, lifting the pancreas forward 
and then resection can be carried out.  
III. Division of stomach (Partial gastrectomy).  
IV. Division of common bile duct with the gallbladder. 
V. Division of the pancreas in front of the portal vein.  
VI. Division and mobilization of the jejunum. 
VII.     Detachment of duodenum and uncinate process of pancreas from   
               superior mesenteric  vessels. 
VIII.       Anastomosis  of  bile  duct  to  jejunum.  Anastomosis  of  pancreas  
              to  jejunum gastrojejunostomy. 
 
 
 Complication 
• Disruption of pancreatojejunal anastomosis.  
• Postoperative hemorrhage from gastrointestinal tract.  
Pylorus – Preserving Pancreatoduodenectomy 
A modification to Whipple’s surgery is by preserving stomach 
and pylorus. The duodenum is transected, usually 3 x 4 cm distal to the 
pylorus and re-anastomosed to the jejunum at the point where a 
gastrojejunostomy would have been done in the standard operation. The 
remaining aspect of the procedure are no different. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 22: Pancreatoduodenectomy 
 
 
 
 
 
 
 METHODOLOGY 
 
Source of Data 
 
Patients admitted to the Department of General Surgery at Thanjavur 
Medical College were taken up for the study. Number of cases studied were 
30 from   September 2013   to  September 2014. 
Method of Collection of Data 
 
After admission to TMCH Hospital, a detailed clinical history and 
examination of the patient was done. Relevant investigations were 
undertaken to make a diagnosis. Patients were assessed preoperatively for 
the fitness for surgery and later subjected to curative or palliative surgery 
depending on the stage of the disease and general condition of the patient. 
The resected tissue was subjected to histopathological examination. 
Postoperatively, patients’ condition was assessed and complications were 
documented. Photographic documentation has been done wherever possible. 
Inclusion criteria 
• Age – More than 12 years.  
•  Patients proved to have obstructive jaundice by any investigative 
modality during the  period from September 2013 to September 2014. 
 
• Exclusion criteria 
 • Age less than 12 years  
 
• Medical jaundice  
 
• Cases of obstructive jaundice who are unfit for interventional 
treatment  
Statistical Methods 
Chi-square and Fisher Exact test have been used to find the 
significance of proportion of symptoms & signs between benign and 
malignant cases. Student t test has been used to find the significance of mean 
difference of lab parameters between benign and malignant cases. The Odds 
ratio has been used to find the strength of relationship between symptoms & 
signs of benign and malignant cases. If p value was <0.05 the probability 
was considered to be statistically significant. 
  
  
RESULTS AND OBSERVATIONS 
Study Design 
A Prospective clinical study consisting of 30 cases of Obstructive 
jaundice was undertaken to investigate the pattern of clinical presentation & 
lab parameters, to study the cause of obstructive jaundice and the different 
modes treatment adopted. 
 
 
Table 1 
Age & Sex distribution 
 
Age in 
years 
Male (n=20) 
Female 
(n=10) Total (n=30)  
       
No. % No. % No. % 
 
  
        
≤ 40 2 10.00 4 40.00 6 20.00  
        
41-50 10 40.00 0 0 8 26.67  
        
51-70 6 30.00 6 60.00 12 40.00  
        
>70 2 10.00 2 20.00 4 13.33  
        
 
 
  
Figure 1: Age distribution of study population 
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                Figure 2: Sex distribution of study population 
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The above table shows analysis of age and sex distribution. The age 
varied from 34 years to 75 years. Number of male patients was 20 (66.7%) 
and number of female patients was 10 (33.3%). 
 Table 2 
 
Association of symptoms & signs with diagnosis 
 
 
Symptoms 
Benign Malignant Total Significance Odds Ratio 
 
(n=20) (n=10) (n=30) (p value) (Malignant)  
 
 
      
 
Pain abdomen 
20 2 22 < 0.001 0.016 
 
(100.00) (20.00) (73.33) Sig. NR  
 
 
      
 
Flatulent dyspepsia 
14 4 18 > 0.05 0.286 
 
(70.00) (40.00) (60.00) NS NR  
 
 
      
 
Jaundice 
12 8 20 > 0.05 2.667 
 
(60.00) (80.00) (66.67) NS R+  
 
 
      
 
Itching 
10 6 16 > 0.05 1.5 
 
(50.00) (60.00) (53.33) NS R+  
 
 
      
 
High Colored Urine 
12 8 20 > 0.05 2.667 
 
(60.00) (80.00) (66.67) NS R+  
 
 
      
 
Clay colored Stools 
8 8 16 > 0.05 6 
 
(40.00) (80.00) (53.33) NS R+  
 
 
      
 
Nausea/Vomiting 
12 4 16 > 0.05 0.44 
 
(60.00) (40.00) (53.33) NS NR  
 
 
      
 
Fever 
14 2 16 > 0.05 0.107 
 
(70.00) (20.00) (53.33) NS NR  
 
 
      
 
Loss of appetite 
10 8 18 > 0.05 4 
 
(50.00) (80.00) (60.00) NS R+  
 
 
      
 
Malena 
2 8 10 > 0.001 36 
 
(10.00) (80.00) (33.33) Sig R+  
 
 
      
 
Pallor 
8 8 16 > 0.05 6 
 
(40.00) (80.00) (53.33) NS R+  
 
 
      
 
Palpable GB 
2 8 10 < 0.001 36 
 
(10.00) (80.00) (33.33) Sig. R+  
 
 
      
 
  
 
 
 
 
 
Figure 3: Bar chart showing percentage distribution of presenting symptoms and 
 
signs of benign and malignant cause of obstructive jaundice 
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1: Pain abdomen  
 
2: Flatulent Dyspepsia  
 
3: Jaundice  
 
4: Itching  
 
5: High colored urine  
 
6: Clay colored stools  
 
7: Nausea/vomiting  
 
8: Fever  
 
9: Loss of appetite  
 
10: Malena 
 
11: Pallor  
 
12: Palpable Gall  
 
Bladder 
  
 
 
 
The above analysis shows the incidence of presenting symptoms and 
signs. 
• Pain abdomen was present in 22 patients (73.33%) with 100% of 
patients with benign and 20% of patients with malignant etiology 
presenting with this symptom. This was found to be statistically 
significant without any increase in risk for a malignant etiology.  
• Flatulent Dyspepsia which includes bloating, belching or heart burn 
was present in 18 patients (60%) with 70% of patients of benign and 
70% of patients with malignant etiology presenting with this symptom 
but was not statistically significant without an increase in risk.  
 
• Jaundice was present in 20 patients (67%). Jaundice in benign 
condition – 
 
12 patients (60%) and in malignant condition, 8 patients (40%). 
Jaundice had 3 times the risk for a malignant cause, however not 
statistically significant. 
 
• Itching was present in 16 patients (53%). In benign condition – 50% 
and malignant condition – 60% with a 2 times increased risk for 
malignancy which was not statistically significant.  
  
  
 
 
• High coloured urine was present in 20 patients (67%). In benign 
condition – 60% and malignant condition it was 80% prevalent with a 
3 times increased risk for the cause to be malignant, but not 
statistically significant.  
• Clay coloured stools was present in 16 patients (53%). In benign 
condition, it was 40% prevalent and in malignant condition 80%, with 
a 6 times increased risk which was statistically significant.  
• Nausea and vomiting was present in 16 patients (53%). In benign 
condition the prevalence was 60% and in malignant condition 40% 
prevalent with no increased risk or statistical significance.  
• Fever was present in a total of 16 patients (53%) with benign 
condition- 70% and malignant condition 20% prevalence with no 
increased risk or statistical significance.  
• Loss of appetite was present in 18 patients. In benign condition, it was 
50% and in malignant condition it was 80% with a 4 times increased 
risk of being malignant with no significant difference among the 2 
groups.  
  
 
• Malena was present in 10 patients who were diagnosed as obstructive 
jaundice, with 36 times increased risk for malignancy with statistical p 
value < 0.05 .  
 
• Pallor was present in a total of 16 (53%) patients, with benign 
condition (40%) and in malignant condition it was 80% with an 
increased risk for malignancy but no significant difference was 
noticed between the 2 groups.  
 
• Gall Bladder was palpable in 10 patients (33%). In patients with 
benign condition 10% and malignant condition 80% prevalence with a 
36 times increased risk for malignancy was noted with a p value < 
0.05 which was statistically significant for a malignant etiology.  
 
  
  
 
 
Table 3 
 
 
Laboratory investigations in comparisons of benign with malignant 
 
 Benign Malignant    
 (n=20) (n=10) Student t test   
Lab parameters 
  
value 
  
Mean ±SD Mean ±SD p value 
 
   
      
Hemoglobin (gm 
10.54±1.86 9.84±0.38 0.818 
> 0.05  
%) 
NS 
 
     
      
Total Bilirubin 
7.12±7.06 15.26±5.786 2.219 
< 0.05  
(mg/dl) Sig. 
 
    
      
Direct Bilirubin 
4.65±4.55 12.72±5.81 2.96 
< 0.05  
(mg/dl) Sig. 
 
    
      
Alkaline 
243±212.75 470.8±150.77 2.12 
< 0.05  
Phosphatase IU 
Sig. 
 
     
      
 
 
  
Figure 4: Bar diagram showing comparison of total and direct bilirubin 
levels in 
 
benign and malignant conditions 
 
 
 
 
 
  
     
 
 
 
 
 
 
Mean hemoglobin in benign was 10.54g/dL with SD 1.86 and 9.84g/dL 
with 0.38 in malignant with no significant difference. 
     Mean total bilirubin in benign is 7.12mg/dL with SD 7.06 and is 
15.26mg/dL with SD 5.786 in malignancy and the similar values of direct 
were 4.65mg/dL with SD 4.55 and 12.72mg/dL with SD 5.81 respectively. 
Both these tests had a statistically significant difference between benign and 
malignant conditions. 
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bilirubin 
 
  
Benign 7.13 4.66  
Malignant 15.27 12.71  
  
              Mean alkaline phosphatase in benign condition is 243IU/L with SD 
212.75 and mean alkaline phosphatase in malignant condition is 470.8IU/L 
with SD 150.77 which was significantly raised in malignancy (p<0.05). 
               In the radiological studies, ultrasound was used as the main 
diagnostic procedure in this study. 60% of patient had common bile duct 
calculi and 33.33% of patient was 
 
diagnosed to have a malignant lesion. 6.67% of patient the diagnosis could 
not be ascertained by ultrasound. This was diagnosed as common bile duct 
benign stricture by an MRCP examination. 
The other investigations done were CT scan, which was done in most 
patients to confirm diagnosis of USG and to know any metastasis in case of 
malignancy. 
MRCP was also done in 25 patients to confirm the diagnosis. 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
Table 4 
 
Etiology of obstructive jaundice 
 
 
Diagnosis No. of cases Percentage of total 
Choledocholithiasis 18 60% 
Benign CBD Stricture 2 6.67% 
Periampullary carcinoma 6 20% 
Ca head of pancreas 4 13.33% 
 
  
60
6.67
20
13.33
Fig.5 Etiology of obstructive jaundice
Choledochlithiasis
Benign CBD Stricture
Periampullary carcinoma
Ca Head of Pancreas
  
 
Table 5 
 
Operative Procedures 
 
 
 Procedure No. of cases 
Percentage of 
total 
   
Cholecystectomy  with  ECBD  
& 10 33.33% 
choledochoduodenostomy   
   
Cholecystectomy with ECBD 8 26.67% 
& T tube drainage   
   
Whipple’s Procedure 4 13.33% 
    
Palliativ
e 
Cholecystojejunosto
my 6 20% 
with jejunojejunostomy   
   
Roux en Y Hepatico-
Jejunostomy 2 6.67% 
    
 
  
  
 
Cholecystectomy and CBD exploration with T
in 8 patients and choledochoduodenostomy in 10
only 2 patients (22.22%) developed peritubal leak which subsided 
spontaneously. 
Two patient
previous Cholecystectomy underwent Roux en Y Hepatico
enteroenterostomy. One
was treated with antibiotics & right pleural effusion which was treated with 
intercostal drainage. 
 
20
-tube drainage for CBD calculi  
 patients. Of these 9 patients 
s  diagnosed to have benign CBD stricture with history 
-Jejunos
 patient developed bile leak with cholangitis which 
 
26.67
13.33
6.67
Fig.6 OPERATIVE PROCEDURES
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Types of malignancies causing obstructive
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Fig .7  Types of malignancies
Table 6 
 jaundice (n=10
 No. of cases 
Percent of malignant 
cases 
  
 4 40%
  
 4 40%
  
2 20%
  
part - - 
  
  
) 
 
 
 
 
CAH
CAV
CACBD
CAD
  
Malignant cause for obstruction was seen in 10 patients (33.33%) . Ca 
head of pancreas was seen in 4 patients, distal cholangiocarcinoma in 2 
patients and Carcinoma of Ampulla of Vater in 4 patient, on 
histopathological examination of the resected specimen. 
Table 7 
 
Post operative complications 
 
Complications No. of cases Percentage of total 
   
Peritubal leak with cholangitis 3 20% 
   
Rt. Pleural effusion 1 6.67% 
   
Death 1 6.67% 
   
 
 
Patients were followed up during the post operative period for 6 
months. One patient with palliative cholecystojejunostomy with 
jejunojejunostomy again for Ca Head of Pancreas died on the 15th post 
operative day due to sepsis. 
 
3 case that underwent Whipple’s procedure for Carcinoma Ampulla of 
Vater during his follow up was asymptomatic except for delayed gastric 
emptying which was treated with prokinetic drugs. 
  
  
Table 8 
                              Outcome of operative procedures 
 
 Mean Pre-op D. PO Day 7 Mean 
Rate of fall of 
D. 
Procedure  D.Bilirubin Bilirubin 
 
Bilirubin(mg/dL
) (mg/dL) (mg/dL/day) 
Cholecystectomy + 
ECBD + 4.26 1.15 0.50 
Choledochoduodenostom
y    
    
Cholecystectomy+ECBD 6.05 2.72 0.475 
+T tube drainage    
    
Palliative 12.6 3.6 1.28 
Cholecystojejunostomy    
    
 
Cholecystectomy with exploration of the CBD and drainage 
was associated with a significant fall in direct Bilirubin values which 
occurred approximately at the rate of 0.5 mg/dL/day. Palliative 
cholecystojejunostomy for obstructive jaundice in patients who have tumors 
which are not resectable, have also shown to decrease the direct bilirubin 
sizably, at the rate of approximately 1.2 mg/dL/day. 
 DISCUSSION 
 
Obstructive jaundice is a frequent condition of biliary tract disorders and 
the evaluation and management of the jaundice patient is a common problem 
facing the General Surgeon. While diagnosing a case of surgical jaundice, a 
thorough history, a complete physical examination & biochemical tests are 
necessary. Once diagnosed, the surgeon should have good knowledge about the 
anatomy of the biliary tree, physiology of bile metabolism and 
pathophysiological changes occurring in the liver, secondary to obstruction, 
various causes of obstruction, different imaging facilities and different 
modalities of treatment. 
In this study, analysis of the various causes of surgical jaundice & its 
presentation were done. Investigations were carried out and different types of 
operative procedures were conducted. Total number of cases were 30. The 
results were compared with other similar studies done by various authors. 
In this study, the peak incidence of surgical jaundice was seen in age 
group of 51 to 70 years with M : F :: 66.67 : 33.33%. 
The common presentation in a benign condition was pain abdomen and 
flatulent dyspepsia, whereas in malignant condition it was jaundice, high 
coloured urine, pale stool & loss of appetite. Most malignant cases had Icterus 
and a palpable gall bladder when compared to benign condition. These 
conditions also carried an increased risk for malignancy as calculated by the 
 odds ratio. 
 
There were significantly higher values of total bilirubin, direct Bilirubin and 
alkaline phosphatase in malignant conditions. 
It was found that obstructive jaundice secondary to common bile duct 
stones remains the commonest cause, obstructive jaundice secondary to 
malignancy was the second most common cause followed by benign stricture. 
USG abdomen was carried out on all patients as a standard imaging 
technique for investigation on a patient presenting with jaundice. USG was 
successfully used as a cheapest non-invasive tool to know the cause and level 
of obstruction in nearly 93% of the patients (USG was unable to diagnose one 
benign CBD stricture which was diagnosed by ERCP). The limitation of this 
diagnostic test was its high operator dependence. 
ERCP: Its value is its ability to remove stones, stenting and also taking 
tissue for HPE. ERCP is also one of the diagnostic tools used for surgical 
jaundice. 
MRCP: It’s a diagnostic test for imaging of biliary tree. Drawback of 
this imaging technique is its inability to remove calculi, stenting or biopsy 
tissue for HPE.CT scan was also used in selected cases to confirm the 
diagnosis made on USG. 
Patient with obstructive jaundice due to CBD calculi underwent 
 Cholecystectomy with CBD exploration with either T-tube drainage after 
intraoperative cholangiogram 
showed normal flow of dye into duodenum with no residual calculi or 
choledochoduodenostomy. 
Definitive procedure done for benign CBD stricture following Cholecystectomy 
was Hepatico-Jejunostomy with enteroenterostomy. 
Obstructive jaundice due to malignancy, 6 underwent palliative procedure 
and four patients underwent definitive procedure (Whipple’s procedure). The 
outcome of palliative procedures was good. Patients were free from jaundice. 
Present study was compared with those of other authors. It has been 
summarized below 
  
 Table 8 
 
Comparison of presenting symptoms and signs 
 
 Agarwal et al Nadkarni et al Present study 
    
Icterus 100 100 100 
    
Pain abdomen 79.1 53.8 73 
    
Itching 50 73.1 53 
    
Fever 12.5 53.8 53 
    
Nausea/Vomiting 70.9 88.5 53 
    
Clay-coloured 
stools 41.7 92.3 53 
    
 
 
As can be seen jaundice was the main presenting symptom/sign in the study of 
Agarwal and Nadkarni et al. Nausea/Vomiting and Pain abdomen was the other 
major presenting symptoms. In the present study, it is pain abdomen followed 
itching, fever, nausea/ vomiting and clay-coloured stools. 
 
  
  
Table 9 
 
Comparison of etiological distribution71,72 
 
 
Nadkarni et al 
(24) 
Kar et al 
(129) Present study (30) 
    
CBD stones 9 32 9 
    
CBD benign stricture 1 4 1 
    
Malignancy of 
pancreas/CBD 14 93 5 
    
 
 
In our study common bile duct stone were the main etiology for 
jaundice when compared to Nadkarni et al, Kar et al, it was malignancies 
which were common.
 CONCLUSION 
• Common presentation of surgical jaundice is jaundice.  
 
• Palpable GB indicates the etiology to be malignant.  
 
• Common cause for surgical jaundice is CBD calculi.  
 
• USG remains the cheapest, safest and most reliable diagnostic tool in 
the management of surgical jaundice.  
 
• Open exploration of CBD under experienced hands is a good 
treatment modality in the management of obstructive jaundice.  
 
• In malignancies, early detection and staging and proper selection of 
the patient are more important to gain benefit from resection of 
tumour, whereas late presentation and those patients not suitable for 
resection had good improvement in quality of survival with palliative 
surgery.  
• Improving deranged LFT, correction of anaemia and hepatorenal 
problem improves the surgical results (morbidity and mortality). 
                       
    SUMMARY 
 
30 patients were diagnosed to have surgical jaundice in the study 
period from September 2013 to September 2014. The study was conducted 
at the Department of Surgery, Thanjavur medical college, Tamil Nadu. 
A brief introduction and a historical review of biliary tract has been 
presented with a detailed discussion on the surgical anatomy, physiology, 
etiopathogenesis, clinical features, investigations and management of 
surgical jaundice. 
The findings of this study were compared with those available in 
literature. The results have been represented with tables and graphs for better 
understanding. 
The findings of the study are as follows: 
1. The occurrence of surgical jaundice was maximum in the 51-70 year 
age group.  
2. Icterus was present in all 30 patients. Pain abdomen and flatulent 
dyspepsia were more in benign condition whereas jaundice, clay-
coloured stools, high coloured urine with itching was more common 
in malignancy.  
  
  
3. High values of serum Bilirubin & alkaline phosphatase are noted in 
malignancy.  
4. USG was the cheapest non-invasive investigation used for diagnosis 
of surgical jaundice.  
 
5. Most common cause of obstruction was CBD calculi, followed by 
malignancy, then by benign CBD stricture.  
 
6. For CBD calculi, CBD exploration with cholecystectomy and 
drainage procedure was done by T tube or choledochoduodenostomy.  
 
7. For benign CBD stricture, the patient underwent Hepatico-
Jejunostomy with enteroenterostomy.  
 
8. For malignancy operative curative procedure was Whipple’s surgery 
and palliative procedure was Cholecystojejunostomy.  
 
9. Recently increasing reliance of ERCP and MRCP to image biliary 
tract has helped to diagnose the pathology earlier and hence early 
intervention can be initiated.  
 
